A Phase 1, Open-label, Two-cohort, Single Dose Study to Assess the Mass Balance, Route of Elimination, and Metabolic Profile of [14C] Labeled CRN00808 and Absolute Bioavailability of CRN00808 in Healthy Male Volunteers
Latest Information Update: 23 Jun 2020
At a glance
- Drugs Paltusotine (Primary) ; Paltusotine (Primary) ; Paltusotine (Primary)
- Indications Acromegaly
- Focus Pharmacokinetics
- Sponsors Crinetics Pharmaceuticals
Most Recent Events
- 11 Feb 2020 New trial record